In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology. The antibody approach offers greater target specificity as well as a new way forward with previously challenging targets, such as ion channels and g-coupled protein receptors. With increased numbers of antibody drug entities entering the pipeline, antibody therapeutics will continue to dominate the drug discovery landscape. Frank Fan, GenScript's Director of Antibody and Protein Engineering will discuss the different approaches to antibody drug discovery and how these approaches can help achieve an antibody lead candidate.
| Biologics drug discovery | ||
|---|---|---|
| Antibody sequencing | Stable cell line for assay development | |
|
| |
| Get Quote | Get Quote | |
